Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 192.84% | -154.65% | 223.71% | 259.35% | 1.62% |
| Total Depreciation and Amortization | -21.77% | -28.54% | -45.91% | -35.77% | -38.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -161.88% | 284.42% | -104.34% | -219.69% | 136.82% |
| Change in Net Operating Assets | 634.21% | -83.82% | 122.63% | -70.29% | 118.67% |
| Cash from Operations | -38.98% | -55.14% | -41.67% | 27.18% | 387.47% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 69.16% | 77.53% | 86.26% | 76.34% | -22.10% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.78% | -- | -- | -- | 93.36% |
| Cash from Financing | 237.19% | 78.09% | 86.58% | 77.28% | -3.51% |
| Foreign Exchange rate Adjustments | -390.74% | 103.33% | -61.11% | -757.14% | -59.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.72% | -10.48% | 896.72% | 158.68% | 77.32% |